000 | 01445 a2200373 4500 | ||
---|---|---|---|
005 | 20250518040425.0 | ||
264 | 0 | _c20191211 | |
008 | 201912s 0 0 eng d | ||
022 | _a1873-264X | ||
024 | 7 |
_a10.1016/j.jpba.2019.04.035 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aScherf-Clavel, Oliver | |
245 | 0 | 0 |
_aThe contamination of valsartan and other sartans, Part 2: Untargeted screening reveals contamination with amides additionally to known nitrosamine impurities. _h[electronic resource] |
260 |
_bJournal of pharmaceutical and biomedical analysis _cAug 2019 |
||
300 |
_a278-284 p. _bdigital |
||
500 | _aPublication Type: Journal Article | ||
650 | 0 | 4 |
_aAmides _xchemistry |
650 | 0 | 4 | _aAngiotensin II Type 1 Receptor Blockers |
650 | 0 | 4 |
_aChromatography, High Pressure Liquid _xmethods |
650 | 0 | 4 |
_aDrug Contamination _xprevention & control |
650 | 0 | 4 |
_aNitrosamines _xchemistry |
650 | 0 | 4 |
_aTandem Mass Spectrometry _xmethods |
650 | 0 | 4 |
_aValsartan _xchemistry |
700 | 1 | _aKinzig, Martina | |
700 | 1 | _aBesa, Axel | |
700 | 1 | _aSchreiber, André | |
700 | 1 | _aBidmon, Clemens | |
700 | 1 | _aAbdel-Tawab, Mona | |
700 | 1 | _aWohlfart, Jonas | |
700 | 1 | _aSörgel, Fritz | |
700 | 1 | _aHolzgrabe, Ulrike | |
773 | 0 |
_tJournal of pharmaceutical and biomedical analysis _gvol. 172 _gp. 278-284 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.jpba.2019.04.035 _zAvailable from publisher's website |
999 |
_c29679899 _d29679899 |